Position in EOLS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$75,241
-$113,539 QoQ
Shares Held
18,307
-35.5% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $88,544,808 across 37 Drug Manufacturers - Specialty & Generic names. EOLS ranks #33 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
304,172 | $15,722,650 | |
| 2 | ZTS |
Zoetis Inc.
|
114,814 | $13,572,162 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
21,171 | $12,553,979 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
53,053 | $6,989,202 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
244,343 | $5,847,127 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
67,088 | $5,088,624 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
211,317 | $4,386,940 | |
| 8 | VTRS |
Viatris Inc
|
269,168 | $3,636,459 |
All Filings in EOLS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $75,241 | 18,307 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $188,780 | 28,388 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $160,450 | 26,132 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $309,437 | 33,598 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $404,183 | 33,598 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $378,362 | 34,272 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $522,093 | 32,228 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $349,673 | 32,228 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $288,764 | 20,626 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $206,535 | 19,614 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $179,271 | 19,614 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $142,593 | 19,614 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $165,934 | 19,614 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $147,301 | 19,614 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $157,892 | 19,614 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $227,522 | 19,614 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $220,069 | 19,614 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $21,267 | 2,791 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $163,703 | 12,941 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||